A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis
William J Moore(Northwestern Medicine), Sajal D. Tanna(Nova Medical (United States)), C Boutin(Centre Hospitalier de l’Université de Montréal)
Cited by 5
Related Papers
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults
|JAMA Network Open|2024|75
Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review
|Clinical Infectious Diseases|2024|55
Prevalence of legionellosis among adults: A study of community-acquired pneumonia in France
|Infection|1987|50
Update on therapeutic approaches for invasive fungal infections in adults
|Therapeutic Advances in Infectious Disease|2024|36